source
- Takeda plans to cut 4,500 jobs, about 9% of workforce, under new CEO's restructuring planTakeda announced it will eliminate roughly 9% of its global workforce, affecting about 4,500 positions, over the coming fiscal year. The cuts are part of a restructuring effort that began under th…
- Tirabrutinib and CAR T-cell therapy show promise for relapsed/refractory primary CNS lymphomaExperts highlighted emerging data on tirabrutinib and CAR T-cell therapy as potential new options for patients with relapsed or refractory primary central nervous system lymphoma. CAR T-cell thera…